Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00031591
DRKS00031591
Suspended
未知

Radiobiological characterisation and therapy monitoring of oligo- compared to polymetastatic breast cancer

Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf0 sites50 target enrollmentApril 3, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC50Malignant neoplasm of breast

Overview

Phase
未知
Intervention
Not specified
Conditions
C50
Sponsor
Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf
Enrollment
50
Status
Suspended
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 3, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • •Metastatic breast cancer patient undergoing radiotherapy (RT) of macroscopic tumour to at least one metastatic site
  • •\- \> 18 years
  • •\- Ability to report patient\-reported outcomes in case of palliative radiotherapy
  • •\- Patient gave informed consent

Exclusion Criteria

  • •\- Patients receiving only RT of a tumour bed/resection cavity with no macroscopic lesion

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostainingEsophageal cancer
JPRN-UMIN000025542Tohoku University90
Recruiting
Not Applicable
Biomarker identification of radionuclide therapy-induced radiation responses.Neuroendocrine tumor1002911210014713
NL-OMON51484Moleculaire genetica25
Completed
Not Applicable
Investigating the protocols for radiotherapy to the breast: an evaluation of treatment morbidity, accuracy and efficiencyBreast cancerCancerMalignant neoplasm of breast
ISRCTN34017998HS R&D Regional Programme Register - Department of Health (UK)
Recruiting
Not Applicable
RADprecise - Personalized radiotherapy: incorporating cellular response to irradiation in personalized treatment planning to minimize radiation toxicityC50C61Malignant neoplasm of breastMalignant neoplasm of prostate
DRKS00020290Deutsches Krebsforschungszentrum (DKFZ) / German Cancer Research Center1,050
Completed
Not Applicable
Investigation on radiotherapy treatment effect using perfusion and diffusion-weighted MR imagingtumor
JPRN-UMIN000014439Kyoto Univerisity Hospital